About New Vision Withdrawal Management
Services
Type of Care
Substance use treatment; Detoxification
Service Setting (e.g., Outpatient, Residential, Inpatient, etc.)
Hospital inpatient/24-hour hospital inpatient; Hospital inpatient detoxification
Hospitals
General Hospital (including VA hospital)
Opioid Medications used in Treatment
Buprenorphine used in Treatment; Naltrexone used in Treatment
External Opioid Medications Source
No formal relationship with prescribing entity
Type of Alcohol Use Disorder Treatment
Accepts clients using medication assisted treatment for alcohol use disorder but prescribed elsewhere; This facility administers/prescribes medication for alcohol use disorder
External Source of Medications Used for Alcohol Use Disorder Treatment
In-network prescribing entity; No formal relationship with prescribing entity
Type of Opioid Treatment
Buprenorphine detoxification; Buprenorphine maintenance; Prescribes buprenorphine; Prescribes naltrexone; Relapse prevention with naltrexone; Accepts clients using MAT but prescribed elsewhere; Lofexidine or Clonidine detoxification; Maintenance service with medically supervised withdrawal after stabilization
Pharmacotherapies
Buprenorphine with naloxone; Naltrexone (oral); Clonidine; Medication for mental disorders; Nicotine replacement
Treatment Approaches
Brief intervention
Facility Operation (e.g., Private, Public)
Private for-profit organization
License/Certification/Accreditation
State Substance use treatment agency; State department of health; Healthcare Facilities Accreditation Program (HFAP); Hospital licensing authority; The Joint Commission
Payment/Insurance/Funding Accepted
Federal, or any government funding for substance use treatment programs; IHS/Tribal/Urban (ITU) funds; Medicare; Medicaid; Federal military insurance (e.g., TRICARE); Private health insurance; Cash or self-payment; State-financed health insurance plan other than Medicaid
Special Programs/Groups Offered
Adult women; Adult men; Seniors or older adults; Veterans
Assessment/Pre-treatment
Comprehensive substance use assessment; Outreach to persons in the community; Complete medical history/physical exam; Screening for tobacco use; Screening for substance use; Professional interventionist/educational consultant
Transitional Services
Discharge Planning; Naloxone and overdose education; Outcome follow-up after discharge
Detoxification (medical withdrawal) Services
Alcohol Detoxification; Benzodiazepines Detoxification; Cocaine Detoxification; Methamphetamines detoxification; Opioids detoxification; Medication routinely used during detoxification
Education and Counseling Services
Substance use disorder education
Facility Smoking Policy
Smoking not permitted
Age Groups Accepted
Young Adults; Adults
Sex Accepted
Female; Male
Language Services
Sign language services for the deaf and hard of hearing
Facility Vaping Policy
Vaping not permitted
Ancillary Services
Case management service; Social skills development; Integrated primary care services
Type of Care
Substance use treatment; Detoxification
Service Setting (e.g., Outpatient, Residential, Inpatient, etc.)
Hospital inpatient/24-hour hospital inpatient; Hospital inpatient detoxification
Hospitals
General Hospital (including VA hospital)
Opioid Medications used in Treatment
Buprenorphine used in Treatment; Naltrexone used in Treatment
External Opioid Medications Source
No formal relationship with prescribing entity
Type of Alcohol Use Disorder Treatment
Accepts clients using medication assisted treatment for alcohol use disorder but prescribed elsewhere; This facility administers/prescribes medication for alcohol use disorder
External Source of Medications Used for Alcohol Use Disorder Treatment
In-network prescribing entity; No formal relationship with prescribing entity
Type of Opioid Treatment
Buprenorphine detoxification; Buprenorphine maintenance; Prescribes buprenorphine; Prescribes naltrexone; Relapse prevention with naltrexone; Accepts clients using MAT but prescribed elsewhere; Lofexidine or Clonidine detoxification; Maintenance service with medically supervised withdrawal after stabilization
Pharmacotherapies
Buprenorphine with naloxone; Naltrexone (oral); Clonidine; Medication for mental disorders; Nicotine replacement
Treatment Approaches
Brief intervention
Facility Operation (e.g., Private, Public)
Private for-profit organization
License/Certification/Accreditation
State Substance use treatment agency; State department of health; Healthcare Facilities Accreditation Program (HFAP); Hospital licensing authority; The Joint Commission
Payment/Insurance/Funding Accepted
Federal, or any government funding for substance use treatment programs; IHS/Tribal/Urban (ITU) funds; Medicare; Medicaid; Federal military insurance (e.g., TRICARE); Private health insurance; Cash or self-payment; State-financed health insurance plan other than Medicaid
Special Programs/Groups Offered
Adult women; Adult men; Seniors or older adults; Veterans
Assessment/Pre-treatment
Comprehensive substance use assessment; Outreach to persons in the community; Complete medical history/physical exam; Screening for tobacco use; Screening for substance use; Professional interventionist/educational consultant
Transitional Services
Discharge Planning; Naloxone and overdose education; Outcome follow-up after discharge
Detoxification (medical withdrawal) Services
Alcohol Detoxification; Benzodiazepines Detoxification; Cocaine Detoxification; Methamphetamines detoxification; Opioids detoxification; Medication routinely used during detoxification
Education and Counseling Services
Substance use disorder education
Facility Smoking Policy
Smoking not permitted
Age Groups Accepted
Young Adults; Adults
Sex Accepted
Female; Male
Language Services
Sign language services for the deaf and hard of hearing
Facility Vaping Policy
Vaping not permitted
Ancillary Services
Case management service; Social skills development; Integrated primary care services
